NO961725L - Endoteliareseptorantagonister - Google Patents
EndoteliareseptorantagonisterInfo
- Publication number
- NO961725L NO961725L NO961725A NO961725A NO961725L NO 961725 L NO961725 L NO 961725L NO 961725 A NO961725 A NO 961725A NO 961725 A NO961725 A NO 961725A NO 961725 L NO961725 L NO 961725L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- aryl
- cycloalkyl
- hydrogen
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det blir fremskaffet nye forbindelser representert ved den generelle formel I: hvor R1 er rettledet eller forgrenet lavere alkyl, en cykloalkyl lavere alkyl, en aryllavere alkyl, en cykloalkyl, en aryl, en arylcykloalkyl, lavere alkokey, en aryloksy, eller en heteroaryl; R2 er hydrogen, en rett eller forgrenet lavere alkyl, en cykloalkyl eller en cykloalkyl lavere alkyl; R3 og R3, er hver Ilke eller forskjellige og er hver hydrogen, en rettkjedet eller forgrenet lavere alkyl, en cykloalkyl, en aryl lavere alkyl, en aryl, eller en heteroaryl; eller R3 og R3> danner sammen en rlngstruktur; R3» er hydrogen, lavere alkyl eller en aryl; eller R2 og R3« danner sammen en lavere alkylengruppe -(CH2)n- hvor n er et helt tall på l, 2,4 eller 3; eller R2 og R3« danner sammen en gruppe representert ved formelen: -(CHo^-Ar- eller -Ar-(CH2)p, hvor p er null eller et helt tall på l eller 2, og Ar er en arylen eller heteroarylen; C(-X) er C(-0), C(-S), C(-NH)-, C(-N-lavere alkyl); C-NH-OH, eller CH2; Y er en dlrekteblndlng, -NH-, en lavere alkyl-N<^ , et oksygenatom, eller metylen; eller C(-X) er CHOH og Y er en direkte binding eller metylen; 84 er -(CH2)s-Ar' hvor s er null eller et helt tall på l, 2 eller 3; og Ar' er aryl, eller en heteroaryl; og RS er karboksy, substituert eller ikke- substltuert karboksamld, PO(OH)2t tetrazol, C^OH, CN, eller hydrogen; og salter derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93810760 | 1993-11-01 | ||
PCT/EP1994/003418 WO1995012611A1 (en) | 1993-11-01 | 1994-10-17 | Endothelin receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961725L true NO961725L (no) | 1996-04-29 |
NO961725D0 NO961725D0 (no) | 1996-04-29 |
Family
ID=8215056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961725A NO961725D0 (no) | 1993-11-01 | 1996-04-29 | Endoteliareseptorantagonister |
Country Status (12)
Country | Link |
---|---|
US (1) | US5780498A (no) |
EP (1) | EP0728145A1 (no) |
JP (1) | JPH09504302A (no) |
AU (1) | AU691201B2 (no) |
BR (1) | BR9407933A (no) |
CA (1) | CA2173875A1 (no) |
FI (1) | FI961804A (no) |
IL (1) | IL111431A0 (no) |
NO (1) | NO961725D0 (no) |
RU (1) | RU2126418C1 (no) |
WO (1) | WO1995012611A1 (no) |
ZA (1) | ZA948541B (no) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996033170A1 (en) * | 1995-04-21 | 1996-10-24 | Novarits Ag | N-aroylamino acid amides as endothelin inhibitors |
AU7130296A (en) * | 1995-09-28 | 1997-04-17 | Ciba-Geigy Japan Limited | Antagonists of endothelin receptors |
IT1291823B1 (it) * | 1997-04-08 | 1999-01-21 | Menarini Ricerche Spa | Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche |
GB9708119D0 (en) * | 1997-04-22 | 1997-06-11 | Glaxo Group Ltd | Chemical compounds |
US6221888B1 (en) | 1997-05-29 | 2001-04-24 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
US6291511B1 (en) | 1997-05-29 | 2001-09-18 | Merck & Co., Inc. | Biarylalkanoic acids as cell adhesion inhibitors |
DE19745146A1 (de) | 1997-10-14 | 1999-04-15 | Basf Ag | Neue pharmazeutisch wirksame Verbindungen, ihre Herstellung und Verwendung |
GB9723407D0 (en) * | 1997-11-05 | 1998-01-07 | Ciba Geigy Ag | Organic compounds |
US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
US6191171B1 (en) | 1997-11-20 | 2001-02-20 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
US6090841A (en) * | 1997-11-21 | 2000-07-18 | Merck & Co., Inc. | Substituted pyrrole derivatives as cell adhesion inhibitors |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6426354B1 (en) | 1998-04-23 | 2002-07-30 | Novartis Ag | Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
EP1073674A1 (en) * | 1998-04-23 | 2001-02-07 | Novartis AG | Thiol inhibitors of endothelin-converting enzyme |
US6423727B1 (en) | 1998-04-23 | 2002-07-23 | Novartis Ag | Certain thiol inhibitors of endothelin-converting enzyme |
GB9811159D0 (en) * | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
CA2360740A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
SI1178958T1 (en) * | 1999-03-15 | 2004-08-31 | Axys Pharmaceuticals, Inc. | N-cyanomethyl amides as protease inhibitors |
KR100679878B1 (ko) * | 1999-04-26 | 2007-02-07 | 아지노모토 가부시키가이샤 | 멜라노사이트-자극 호르몬 억제제 |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
GB0003111D0 (en) | 2000-02-10 | 2000-03-29 | Novartis Ag | Organic compounds |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
WO2002100846A1 (en) * | 2001-06-11 | 2002-12-19 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
MY140707A (en) * | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
US7122580B2 (en) | 2002-08-09 | 2006-10-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
CA2505098A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
WO2005014534A1 (en) * | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
WO2005014533A2 (en) | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
US7208601B2 (en) * | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
GB0514071D0 (en) * | 2005-07-07 | 2005-08-17 | Zealand Pharma As | N- or C- terminally modified small peptides |
US20090012010A1 (en) * | 2007-05-18 | 2009-01-08 | Neuromed Phramaceuticals Ltd. | Amino acid derivatives as calcium channel blockers |
KR20130004579A (ko) * | 2010-02-23 | 2013-01-11 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
US9260427B2 (en) * | 2013-06-11 | 2016-02-16 | Receptos, Inc. | GLP-1 receptor modulators |
WO2015106242A2 (en) * | 2014-01-13 | 2015-07-16 | The General Hospital Corporation | Bisamide compounds as allosteric effectors for reducing the oxygen-binding affinity of hemoglobin |
US10758569B2 (en) | 2014-01-13 | 2020-09-01 | The General Hospital Corporation | Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin |
US10829440B2 (en) * | 2015-06-12 | 2020-11-10 | Brown University | Antibacterial compounds and methods of making and using same |
CN108821994A (zh) * | 2018-05-24 | 2018-11-16 | 三峡大学 | 一类双羟基酰氧基双酰胺类药物中间体及其制备方法 |
US11555010B2 (en) | 2019-07-25 | 2023-01-17 | Brown University | Diamide antimicrobial agents |
RU2716258C1 (ru) * | 2019-07-30 | 2020-03-11 | Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий | Пептидный антагонист нмда-рецептора |
EP4165037A1 (en) | 2020-06-10 | 2023-04-19 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
FR3111544A1 (fr) * | 2020-06-18 | 2021-12-24 | Universite Paris-Saclay | Nouveaux composés dipeptidiques, leur procédé de fabrication et une nouvelle application thérapeutique de composés dipeptidiques. |
RU2769051C1 (ru) * | 2021-06-30 | 2022-03-28 | Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" | Пептид, улучшающий функциональные свойства эндотелия сосудов, фармацевтическая композиция на его основе и способ ее применения |
KR20240035513A (ko) | 2021-07-09 | 2024-03-15 | 알리고스 테라퓨틱스 인코포레이티드 | 항바이러스 화합물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623142B2 (no) * | 1974-07-01 | 1981-05-29 | ||
US4025644A (en) * | 1974-12-18 | 1977-05-24 | Daiichi Seiyaku Co., Ltd. | Tyrosine derivatives and use |
DE2901667A1 (de) * | 1979-01-17 | 1980-07-31 | Troponwerke Gmbh & Co Kg | Pharmazeutische verwendung von dipeptiden |
EP0072058A1 (en) * | 1981-08-10 | 1983-02-16 | Duphar International Research B.V | Multiple-compartment syringe |
US4395401A (en) * | 1981-09-09 | 1983-07-26 | Smithkline Beckman Corporation | Renally active dipeptides |
JPS58133260A (ja) * | 1982-02-02 | 1983-08-08 | 河村 純郎 | 多段注射器 |
DE3332633A1 (de) * | 1983-09-09 | 1985-04-04 | Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München | Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel |
AU589665B2 (en) * | 1985-08-14 | 1989-10-19 | G.D. Searle & Co. | Substituted dipeptide amides |
CA1297633C (en) * | 1985-09-27 | 1992-03-17 | Shosuke Okamoto | Phenylalanine derivative and proteinase inhibitor |
ES2017924B3 (es) * | 1985-10-11 | 1991-03-16 | Duphar Int Res B V | Inyector automatico. |
DE3770294D1 (de) * | 1986-03-14 | 1991-07-04 | Syntex Inc | 3,5-disubstituierte 4,5-dihydroisoxazole als transglutaminasehemmer. |
US5187156A (en) * | 1988-03-16 | 1993-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
CA1326108C (en) * | 1988-04-12 | 1994-01-11 | Sun Hyuk Kim | Cck antagonists |
JPH0347163A (ja) * | 1989-06-30 | 1991-02-28 | Fujisawa Pharmaceut Co Ltd | アントラキノン誘導体およびその製造 |
CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
US5284828A (en) * | 1990-05-14 | 1994-02-08 | Fujisawa Pharmaceutical Co. Ltd. | Peptide compound and its preparation |
CA2043741C (en) * | 1990-06-07 | 2003-04-01 | Kiyofumi Ishikawa | Endothelin antagonistic peptide derivatives |
DK220890D0 (da) * | 1990-09-14 | 1990-09-14 | Ole Buchardt | Fremgangsmaade til fremstilling af c-terminalt amiderede peptider |
EP0668770A1 (en) * | 1991-04-24 | 1995-08-30 | Warner-Lambert Company | $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY |
TW270116B (no) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
DE69231404T2 (de) * | 1991-05-16 | 2001-02-08 | Warner Lambert Co | Endothelinantagonisten |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
RO117847B1 (ro) * | 1991-11-05 | 2002-08-30 | Smithkline Beecham Corp | Derivati de indan, procedeu de preparare, compozitie farmaceutica care ii contine si metoda de tratament |
TW224462B (no) * | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
US5550138A (en) * | 1992-03-25 | 1996-08-27 | Takeda Chemical Industries, Ltd. | Condensed thiadiazole derivative, method of its production, and use thereof |
NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
WO1994002474A1 (en) * | 1992-07-17 | 1994-02-03 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
-
1994
- 1994-10-17 RU RU96112148A patent/RU2126418C1/ru active
- 1994-10-17 JP JP7512982A patent/JPH09504302A/ja active Pending
- 1994-10-17 AU AU78565/94A patent/AU691201B2/en not_active Ceased
- 1994-10-17 BR BR9407933A patent/BR9407933A/pt not_active Application Discontinuation
- 1994-10-17 EP EP94929557A patent/EP0728145A1/en not_active Ceased
- 1994-10-17 CA CA002173875A patent/CA2173875A1/en not_active Abandoned
- 1994-10-17 WO PCT/EP1994/003418 patent/WO1995012611A1/en not_active Application Discontinuation
- 1994-10-17 US US08/637,720 patent/US5780498A/en not_active Expired - Fee Related
- 1994-10-27 IL IL11143194A patent/IL111431A0/xx unknown
- 1994-10-31 ZA ZA948541A patent/ZA948541B/xx unknown
-
1996
- 1996-04-26 FI FI961804A patent/FI961804A/fi unknown
- 1996-04-29 NO NO961725A patent/NO961725D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO961725D0 (no) | 1996-04-29 |
CA2173875A1 (en) | 1995-05-11 |
BR9407933A (pt) | 1996-11-26 |
EP0728145A1 (en) | 1996-08-28 |
WO1995012611A1 (en) | 1995-05-11 |
FI961804A (fi) | 1996-04-30 |
AU691201B2 (en) | 1998-05-14 |
JPH09504302A (ja) | 1997-04-28 |
ZA948541B (en) | 1995-05-02 |
AU7856594A (en) | 1995-05-23 |
IL111431A0 (en) | 1994-12-29 |
RU2126418C1 (ru) | 1999-02-20 |
US5780498A (en) | 1998-07-14 |
FI961804A0 (fi) | 1996-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961725L (no) | Endoteliareseptorantagonister | |
NO20054516L (no) | Fremgangsmate for fremstilling av blokkholdig merkaptosilan | |
US4960678A (en) | Photochromic compounds | |
TWI255944B (en) | Photosensitive resin composition, color filter, and copolymer resin useful for them | |
HK1055302A1 (en) | Aliphatic nitrogenous five-membered ring compounds | |
NO993981L (no) | Sammensetning og fremgangsmÕte for fremstilling av brenselsbestandig flytende polytioeterpolymerer med god lav-temperatur-fleksibilitet | |
DE69824194D1 (de) | Substituierte kondensierte heterocyclische verbindungen | |
EP1026149A4 (en) | AMIDOCARBONSÄUREDERIVATE | |
DK0870765T3 (da) | Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen | |
NZ585454A (en) | Fluoroalkyl silanes generally derived from an isocyanate precursor | |
Mukkala et al. | Influence of Chelating Groups on the Luminescence Properties of Europium (III) and Terbium (III) chelates in the 2, 2′‐bipyridine series | |
WO2007080055A3 (en) | Fluorous telomeric compounds and polymers containing same | |
DE3875058D1 (de) | Organopolysiloxane mit buntesalzgruppen. | |
EA200100310A1 (ru) | Кислородсодержащие гетероциклические соединения | |
CA1197127A (en) | Colourphotographic recording material | |
CA2344134A1 (en) | Hydrolysis-stable and polymerizable acrylophosphonic acid | |
NO974567L (no) | 9-substituerte porfycener | |
Choi et al. | Novel one‐pot polymer syntheses based on dithiols obtained from a five‐membered cyclic dithiocarbonate and diamines | |
KR940010018B1 (ko) | 폴리(티우람 디술피드)류, 그의 제조방법 및 비닐 단량체의 중합 반응에서의 그의 용도 | |
ATE103266T1 (de) | Chalkonderivate. | |
Ho et al. | Novel aryl cyanide synthesis using trichloroacetonitrile | |
EP1708026A4 (en) | PHOTOSENSITIVE POLYMER COMPOSITION, METHOD FOR GENERATING A PATTERN, AND ELECTRONIC COMPONENT | |
US5194646A (en) | Polymerizable silicones having acetylenic unsaturation | |
EP0303279A3 (en) | Reactive hindered amine light stabilizers | |
US3920685A (en) | Dialkoxyphosphonalkyl derivatives of cyclicureides containing glycidyl groups |